Borga O, Borga B
J Pharmacokinet Biopharm. 1997; 25(1):63-77.
PMID: 9353694
DOI: 10.1023/a:1025719827072.
Johnston A, Henry J, Warrington S, HAMER N
Br J Clin Pharmacol. 1980; 10(3):245-8.
PMID: 7437241
PMC: 1430074.
DOI: 10.1111/j.1365-2125.1980.tb01751.x.
Prandota J, Tillement J, dAthis P, Drueke T, Digiulio S
Eur J Drug Metab Pharmacokinet. 1980; 5(2):99-106.
PMID: 7398682
DOI: 10.1007/BF03189452.
Sager G, Hansteen V, Aakesson I, Jacobsen S
Br J Clin Pharmacol. 1981; 12(5):613-20.
PMID: 7332725
PMC: 1401961.
DOI: 10.1111/j.1365-2125.1981.tb01279.x.
Ridd M, Brown K, Moore R, McBRIDE W, Nation R
Eur J Clin Pharmacol. 1982; 22(2):153-60.
PMID: 7094985
DOI: 10.1007/BF00542461.
Protein binding of some non-steroidal anti-inflammatory drugs in rheumatoid arthritis.
Wanwimolruk S, Birkett D, Brooks P
Clin Pharmacokinet. 1982; 7(1):85-92.
PMID: 7075085
DOI: 10.2165/00003088-198207010-00005.
Clinical pharmacokinetics of quinidine.
Ochs H, Greenblatt D, Woo E
Clin Pharmacokinet. 1980; 5(2):150-68.
PMID: 6988137
DOI: 10.2165/00003088-198005020-00003.
Naloxone protein binding in adult and foetal plasma.
ASALI L, Brown K
Eur J Clin Pharmacol. 1984; 27(4):459-63.
PMID: 6519154
DOI: 10.1007/BF00549595.
Disease-induced changes in the plasma binding of basic drugs.
Piafsky K
Clin Pharmacokinet. 1980; 5(3):246-62.
PMID: 6156048
DOI: 10.2165/00003088-198005030-00004.
Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics.
Harashima H, Sawada Y, Sugiyama Y, Iga T, Hanano M
J Pharmacokinet Biopharm. 1985; 13(4):425-40.
PMID: 4087170
DOI: 10.1007/BF01061478.
Plasma free fatty acids and protein binding of disopyramide during haemodialysis.
Horiuchi T, Johno I, Kitazawa S, Goto M, Hata T
Eur J Clin Pharmacol. 1987; 33(3):327-9.
PMID: 3691623
DOI: 10.1007/BF00637572.
Free drug concentration monitoring in clinical practice. Rationale and current status.
Svensson C, Woodruff M, BAXTER J, Lalka D
Clin Pharmacokinet. 1986; 11(6):450-69.
PMID: 3542337
DOI: 10.2165/00003088-198611060-00003.
Inhibitory effect of free fatty acids on plasma protein binding of disopyramide in haemodialysis patients.
Horiuchi T, Johno I, Hasegawa T, Kitazawa S, Goto M, Hata T
Eur J Clin Pharmacol. 1989; 36(2):175-80.
PMID: 2721542
DOI: 10.1007/BF00609191.
Pharmacokinetics of quinidine in male patients. A population analysis.
Verme C, Ludden T, Clementi W, Harris S
Clin Pharmacokinet. 1992; 22(6):468-80.
PMID: 1587058
DOI: 10.2165/00003088-199222060-00005.
Heparin administration increases plasma warfarin binding in man.
Routledge P, Bjornsson T, Kitchell B, SHAND D
Br J Clin Pharmacol. 1979; 8(3):281-2.
PMID: 497095
PMC: 1429800.
DOI: 10.1111/j.1365-2125.1979.tb01016.x.
Protein binding of cardiac glycosides in disease states.
Storstein L
Clin Pharmacokinet. 1977; 2(3):220-33.
PMID: 328208
DOI: 10.2165/00003088-197702030-00006.
